Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Catherine C. Turkel Insider Profile
4 Followers
Catherine C. Turkel, President at Eledon Pharmaceuticals, holds 4.60K shares in Lexaria Bioscience (Ticker: LEXX), holds 88.66K shares in Eledon Pharmaceuticals (Ticker: ELDN). Most recently, Catherine C. Turkel Bought ― shares of Lexaria Bioscience on Aug 13, 2024 for an estimated value of 5.01K.
Catherine C. Turkel Eledon Pharmaceuticals (ELDN)President
Eledon Pharmaceuticals (ELDN)
President
Ranked #57,001 out of 99,335 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-5.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Catherine C. Turkel holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 22, 2019 - May 22, 2020
Return:+46.80%
The most profitable trade made by Catherine C. Turkel
Catherine C. Turkel's Trading History
Eledon Pharmaceuticals
May 22, 2019
President
Informative Sell
18.60K
$439.76K
Lexaria Bioscience
Aug 13, 2024
Director
Informative Buy
5.01K
$10.63K
List of latest transactions for each holding click on a transaction to see Catherine C. Turkel's performance on stock
You May Also Like
Catherine C. Turkel insider profile FAQ
What is the percentage of profitable transactions made by Catherine C. Turkel?
The percentage of profitable transactions made by Catherine C. Turkel is 25%.
What is the average return per transaction made by Catherine C. Turkel?
The average return per transaction made by Catherine C. Turkel is -5.00%.
What stocks does Catherine C. Turkel hold?
Catherine C. Turkel holds: ELDN, LEXX stocks.
What was Catherine C. Turkel’s latest transaction?
Catherine C. Turkel latest transaction was an Informative Buy of $5.01K.
What was Catherine C. Turkel's most profitable transaction?
Catherine C. Turkel’s most profitable transaction was an Informative Sell of ELDN stock on May 22, 2019. The return on the trade was 46.80%.
What is Catherine C. Turkel's role in Eledon Pharmaceuticals?
Catherine C. Turkel's role in Eledon Pharmaceuticals is President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.